018658083

Renzophi

---

February 20, 2022

Trademark Summary

The trademark application Renzophi was filed by Novo Nordisk Health Care AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on March 31, 2022, and it was registered by office on July 8, 2022 without any oppositions.

The application was filed in Danish (English was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with Pharmaceutical preparations for the treatment kidney diseases and treatment of liver diseases, pharmaceutical preparations for the treatment of primary hyperoxaluria.